Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Recruiting × Epilepsy × Clear all

Phase

Phase NA 2 Phase 3 1 Phase 2/3 1 Phase 2 1 Phase 1/2 1

Status

Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 135 Neoplasms 98 Breast Neoplasms 76 Colorectal Neoplasms 74 Leukemia, Myeloid, Acute 71 Pancreatic Neoplasms 70 Neoplasm Metastasis 66 Recurrence 65 Melanoma 65 Multiple Myeloma 61 Prostatic Neoplasms 60 Ovarian Neoplasms 60 Stomach Neoplasms 53 Lung Neoplasms 47 Squamous Cell Carcinoma of Head and Neck 46 Lymphoma 43 Advanced Solid Tumor 42 Precursor Cell Lymphoblastic Leukemia-Lymphoma 41 Triple Negative Breast Neoplasms 40 Glioblastoma 39 Endometrial Neoplasms 37 Lymphoma, Non-Hodgkin 36 Uterine Cervical Neoplasms 32 Carcinoma, Renal Cell 31 Carcinoma, Hepatocellular 30 Advanced Solid Tumors 29 Brain Neoplasms 28 Small Cell Lung Carcinoma 26 Sarcoma 26 Lymphoma, Large B-Cell, Diffuse 26

Interventions

Temozolomide 1 Sulfasalazine 1 Radiotherapy 1 Memantine 1 Gabapentin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05664464 2024-05-10

GLUGLIO

University of Zurich

Phase 1/2 Recruiting

Epilepsy, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡